SCHEMBL8613207

SCHEMBL8613207

COc1cc2c(C(=O)NC(N)=Nc3ccccc3)ccnc2c(OC)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 13/20 0.49
SCN5A Q14524 2/20 0.47
SCN2A Q99250 2/20 0.47
IMPDH2 P12268 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
SCNN1A P37088 1/20 0.40
PSMD14 O00487 1/20 0.40
KDM4E B2RXH2 1/20 0.39
GMNN O75496 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
HPGD P15428 1/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39
STAT6 P42226 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8614883 0.89 SMO (0.46) SMOSCN5ASCN2AIMPDH2SMN1; SMN2
SCHEMBL8616484 0.86 SMO (0.49) SMOSCN5ASCN2AIMPDH2SMN1; SMN2
SCHEMBL8614046 0.86 SMO (0.49) SMOSCN5ASCN2AIMPDH2SMN1; SMN2
SCHEMBL8616307 0.86 SMO (0.43) SMOSCN5ASCN2AIMPDH2SMN1; SMN2
SCHEMBL8617725 0.84 PDE4A (0.46) SMOIMPDH2SMN1; SMN2NPC1RAB9A
SCHEMBL8620870 0.84 SRC (0.47) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8619835 0.84 SMO (0.49) SMOSCN5ASCN2AIMPDH2SMN1; SMN2
SCHEMBL8614772 0.83 SMO (0.43) SMOSCN5ASCN2AIMPDH2SMN1; SMN2
SCHEMBL8617785 0.82 LMNA (0.43) SMOSCN5ASCN2AIMPDH2SMN1; SMN2
SCHEMBL8614354 0.81 SMO (0.43) SMOSCN5ASCN2AIMPDH2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed